Cell-Innovations Pty Limited is an emerging leader in regenerative medicine
Cell-Innovations, based in Sydney, Australia, are international leaders in the field of Regenerative Medicine using autologous Stromal Vascular Fraction (SVF) obtained from your own body fat. The company engages in both clinical and basic science studies in the use of SVF for clinical indications.
Cell-Innovations have developed proprietary technology which uses ultrasound cavitation to extract the adipose Stromal Vascular Fraction (SVF) with extra-cellular matrix from adipose tissue. Unlike other methods of SVF separation, the major advantage of using the Cell-Innovations process is the ease and speed of processing (within 40 minutes). Most significantly, there is no use of chemicals and enzymes, such as collagenase, making our process cleaner and safer.
Cell-Innovations technology does not isolate any particular cell or stem cell from the adipose tissue, nor does it culture cells. Stromal Vascular Fraction contains multiple cell types. Stromal Vascular Fraction therapy has been found to be beneficial, but cannot be considered a stem cell therapy as we do not culture the cells.
Cell-Innovations license the ultrasonic cavitation technology to doctors, hospitals and clinicians throughout Australia, and internationally.